Diabetes and Depression: Causes, Symptoms, and Prevention

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • People with diabetes are about twice as likely to experience clinical depression as the general adult population — and depression raises the risk of developing type 2 diabetes by roughly 60 percent.
  • Untreated depression in diabetes is associated with higher A1C (about 0.5 to 1.0 percentage points), more complications, and roughly double the mortality risk.
  • Sertraline, escitalopram, and other SSRIs are usually first-line because they are weight-neutral; duloxetine helps if neuropathic pain is also present.
  • Tricyclic antidepressants and some atypical antipsychotics may cause weight gain and worsen glycemic control and are typically avoided.
  • Depression and diabetes distress are different — both are common, but they need different treatments.

Diabetes and depression have a strong bidirectional relationship. Diabetes roughly doubles the risk of clinical depression, and depression increases the risk of developing type 2 diabetes by about 60 percent. Untreated depression is associated with higher A1C, more complications, and approximately double the mortality. SSRIs such as sertraline or escitalopram, with or without cognitive behavioral therapy, are the usual first-line treatments. Annual screening using the PHQ-9 is recommended.

Why the Two Are Connected

  • Chronic illness burden. Managing a lifelong condition with daily decisions, lab numbers, and complication fears is itself a depression risk factor.
  • Shared biology. Both conditions involve chronic low-grade inflammation, hypothalamic-pituitary-adrenal axis activation, and vascular changes affecting brain regions involved in mood.
  • Behavioral cascade. Depression reduces physical activity and self-care; reduced self-care worsens glucose and weight; worsening diabetes increases depression.
  • Medication side effects. Some diabetes-related medications (corticosteroids in particular) and some psychiatric medications affect the other condition.

How Common Is Depression in Diabetes?

Population Approximate Depression Prevalence
General US adults 5 to 7 percent at any time
Type 2 diabetes 20 to 25 percent at any time
Type 1 diabetes 12 to 20 percent
Diabetes plus diabetic complications 30 percent or higher

Lifetime prevalence is higher still — roughly one in three adults with diabetes will experience at least one major depressive episode.

Symptoms of Depression in Diabetes

Mood and Cognitive Symptoms

  • Low mood most of the day, nearly every day, for 2 weeks or longer
  • Loss of interest or pleasure in activities (anhedonia)
  • Feelings of worthlessness or excessive guilt
  • Difficulty concentrating or making decisions
  • Recurrent thoughts of death or self-harm

Physical Symptoms

  • Significant weight or appetite change
  • Sleep disturbance (insomnia or hypersomnia)
  • Fatigue or loss of energy
  • Psychomotor slowing or agitation

Diabetes-Specific Patterns

  • Letting glucose monitoring lapse for days or weeks
  • Missing or skipping insulin doses or oral medications
  • Withdrawing from clinic appointments
  • Stopping exercise that was previously enjoyable
  • Eating in ways that feel out of control or punitive
  • Hopelessness about long-term diabetes outcomes

Effect on Diabetes Outcomes

  • A1C. Depression is associated with approximately 0.5 to 1.0 percentage point higher A1C on average.
  • Complications. Roughly double the risk of micro- and macrovascular complications, including retinopathy, nephropathy, and cardiovascular events.
  • Mortality. Approximately twice the all-cause mortality of diabetes without depression.
  • Quality of life. Measurably lower across physical, social, and emotional domains.
  • Healthcare use. More emergency visits, more hospitalizations, less attendance at scheduled care.

Depression vs Diabetes Distress

These overlap but are different and need different treatments.

Feature Major Depression Diabetes Distress
Core complaint Pervasive low mood, anhedonia Burden and frustration specifically about diabetes
Mood outside diabetes context Also low Often normal
Prevalence in diabetes ~20 to 25 percent ~30 to 40 percent
Screening tool PHQ-9 DDS or PAID
First-line treatment SSRI and/or CBT Diabetes-specific behavioral support, education, sometimes peer support

See the dedicated overview of diabetes distress for more on the distress construct, and the companion piece on diabetes and anxiety.

Screening

  • PHQ-2. A 2-question screen — over the past 2 weeks, how often have you felt down or had little interest? Score 3 or higher prompts the full PHQ-9.
  • PHQ-9. Nine items scored 0 to 3; total 0-27. Cutoffs: 5 mild, 10 moderate, 15 moderately severe, 20 severe. The ADA recommends screening annually and at major transitions (new diagnosis, hospitalization, new complication, life events).
  • Beck Depression Inventory (BDI-II). Used in research and some clinical settings.
  • Any positive screen requires a clinical interview to confirm diagnosis and assess safety.

Treatment Options

Psychotherapy

  • Cognitive behavioral therapy (CBT). Evidence base supports CBT for both depression and improved glycemic control.
  • Behavioral activation. Structured re-engagement with activities; particularly useful when fatigue and anhedonia dominate.
  • Interpersonal therapy (IPT). Helps when relationship stressors and grief contribute.
  • Mindfulness-based cognitive therapy. Reduces relapse risk.

Medications — Preferred in Diabetes

Medication Class Notes
Sertraline SSRI Weight-neutral; commonly used first-line
Escitalopram SSRI Weight-neutral; well-tolerated
Fluoxetine SSRI May modestly improve glucose; long half-life
Duloxetine SNRI Also FDA-approved for diabetic peripheral neuropathy pain
Bupropion NDRI Weight-neutral or weight loss; avoid if seizure history

Medications to Use With Caution

  • Tricyclics (amitriptyline, nortriptyline). Effective for neuropathic pain but cause weight gain, dry mouth, sedation; QT prolongation in higher doses.
  • Mirtazapine. Effective antidepressant but significant weight gain.
  • Paroxetine. More weight gain than other SSRIs.
  • Some atypical antipsychotics (olanzapine, quetiapine). Significant metabolic side effects; reserved for specific indications.

Lifestyle Components That Help Both Conditions

  • Aerobic exercise. Even 150 minutes per week of moderate activity has antidepressant effects similar to medications in mild to moderate depression and improves insulin sensitivity.
  • Sleep. Poor sleep worsens both depression and glucose; treating sleep apnea, restless legs, and insomnia helps both.
  • Light therapy. Useful for seasonal patterns and shift workers.
  • Social connection. Peer support, support groups (including diabetes-specific groups), reducing isolation.
  • Nutrition. A Mediterranean-style pattern has small but consistent antidepressant effects; see diet and nutrition.
  • Alcohol moderation. Alcohol is a depressant and disrupts glucose.

When to Seek Urgent Help

  • Any thoughts of self-harm, suicide, or wanting to be dead
  • Plans or means to harm oneself
  • Inability to perform basic self-care (eating, taking medications, getting out of bed)
  • Severe anxiety with panic attacks
  • Acute psychosis
  • In the US the 988 Suicide and Crisis Lifeline is available 24/7

See the broader complications hub and the ADA 2024 Standards of Care section on psychosocial care for the underlying evidence.

The Bottom Line

Depression affects roughly one in four adults with diabetes and is strongly linked to higher A1C, more complications, and worse mortality. Annual screening with the PHQ-9, careful distinction from diabetes distress, and treatment with weight-neutral SSRIs (sertraline, escitalopram) or duloxetine — combined with CBT, exercise, and sleep support — usually leads to meaningful improvement in both mood and glucose. Anyone with persistent low mood, loss of pleasure, sleep changes, or thoughts of self-harm should talk to their clinician promptly; in a crisis, call 988.

Frequently Asked Questions

How are diabetes and depression linked?

The link is bidirectional. Diabetes roughly doubles the risk of clinical depression, likely through chronic illness burden, inflammation, vascular changes affecting the brain, and the daily demands of self-management. Depression also increases the risk of developing type 2 diabetes by about 60 percent, probably through inactivity, weight gain, poor sleep, and stress-related cortisol elevation.

How does depression affect blood sugar?

Depression often reduces motivation for the daily tasks diabetes requires — checking glucose, taking medications consistently, planning meals, and exercising. The result is higher A1C — meta-analyses show roughly a 0.5 to 1.0 percentage point increase. Some antidepressants also affect weight and glucose. Treating the depression frequently improves glycemic control along with mood.

What antidepressants are safest in diabetes?

SSRIs such as sertraline and escitalopram are usually first-line because they are weight-neutral or only mildly weight-affecting. Duloxetine (an SNRI) is a useful choice when painful diabetic neuropathy coexists. Tricyclic antidepressants (amitriptyline, nortriptyline) tend to cause weight gain and may worsen glucose. Several atypical antipsychotics raise glucose and weight substantially and are not used as first-line antidepressants in diabetes.

How is depression diagnosed in someone with diabetes?

A clinician uses a structured screening tool such as the Patient Health Questionnaire (PHQ-9) — nine questions about mood, sleep, appetite, energy, and self-worth over the prior 2 weeks. A score of 10 or higher suggests at least moderate depression and warrants a full clinical interview. The ADA recommends screening annually and at care transitions.

Sources

  1. American Diabetes Association. Standards of Care in Diabetes 2024 (Section 5 Facilitating Behavior Change and Well-being).
  2. Lustman PJ et al. Depression and Poor Glycemic Control A Meta-Analytic Review. Diabetes Care.
  3. Polonsky WH et al. Assessing Psychosocial Distress in Diabetes (PAID, DDS).
  4. Anderson RJ et al. The prevalence of comorbid depression in adults with diabetes. Diabetes Care 24(6).